| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA744111 | F | Tested for in vitro cell growth inhibition of NCI-N417 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 2. | ALA744112 | F | Tested for in vitro cell growth inhibition of NCI-N417 cells; No significant effect | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 3. | ALA752387 | F | Compound was evaluated for inhibitory activity against N 417 human lung cancer cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 4. | ALA752388 | F | Cytotoxicity against N 417 human lung cancer cell line | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
| 5. | ALA751474 | F | In vitro tumor cell growth inhibitory activity against Human lung small-cell carcinoma cell NCI-H-417 | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 6. | ALA1243868 | F | Anticancer activity against human NCI-N417 cells xenografted in athymic mouse assessed as tumor caspase-3 cleavage at 100 mg/kg, ip administered daily for 5 consecutive days measured after 12 hrs post last dose by immunohistochemistry | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA1243869 | F | Anticancer activity against human NCI-N417 cells xenografted in athymic mouse assessed as decrease in tumor Akt activity at 100 mg/kg, ip administered daily for 5 consecutive days measured after 12 hrs post last dose by immunohistochemistry | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 8. | ALA1243870 | F | Anticancer activity against human NCI-N417 cells xenografted in ip dosed athymic mouse assessed as tumor caspase-3 cleavage administered daily for 5 consecutive days measured after 12 hrs post last dose by immunohistochemistry | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA1243871 | F | Anticancer activity against human NCI-N417 cells xenografted in ip dosed athymic mouse assessed as decrease in tumor Akt activity administered daily for 5 consecutive days measured after 12 hrs post last dose by immunohistochemistry | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA1243872 | F | Anticancer activity against human NCI-N417 cells xenografted in athymic mouse assessed as decrease in tumor Akt activity at 75 mg/kg, ip administered daily for 5 consecutive days measured after 6 hrs post last dose by immunohistochemistry | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA1243873 | F | Anticancer activity against human NCI-N417 cells xenografted in athymic mouse assessed as decrease in tumor Akt activity at 75 mg/kg, ip administered daily for 5 consecutive days measured after 36 hrs post last dose by immunohistochemistry | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA1243874 | F | Anticancer activity against human NCI-N417 cells xenografted in athymic mouse assessed as tumor growth inhibition at nontoxic dose administered ip daily for 5 consecutive days measured on day 20 post tumor implantation | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA2015364 | F | Cytotoxicity against human NCI-N417 cells after 96 hrs by trypan blue exclusion assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 14. | ALA2400506 | F | Cytotoxicity against human NCI-N417 cells after 96 hrs by trypan blue exclusion assay | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 15. | ALA3117385 | F | Cytotoxicity against human NCI-N417 cells after 96 hrs by Cell-Titer Blue assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 16. | ALA5261779 | F | Cytotoxicity against human NCI-H417 cells measured after 8 days | Homo sapiens | 2 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!